The pathologic and clinical features of coronavirus disease 19 may be mechanistically linked to an increased risk for disseminated intravascular coagulation and propensity for diffuse alveolar hemorrhage.
An increase in hospitalizations for acute myocardial infarction-rheumatoid arthritis was observed between 2002 and 2016, with rheumatoid arthritis found to be independently associated with lower in-hospital mortality in patients with acute myocardial infarction.
The estimation of myocardial flow reserve using positron emission tomography may help identify patients with ischemic heart failure who would have improved outcomes with early coronary artery bypass grafting vs percutaneous coronary intervention.
The treatment of patients with dual antiplatelet therapy after a percutaneous coronary intervention was found to be associated with a reduction in de novo atherothrombotic ischemic events.
Although mortality rates associated with cardiovascular disease have decreased significantly in high-income countries in recent decades, substantial challenges related to CVD treatment and outcomes persist in rural areas.
Further studies are required to establish the predictive value of fragmented QRS detail characteristics for ventricular tachyarrhythmias in patients with acute myocardial infarction.
This was the first randomized controlled trial comparing a delayed vs immediate invasive strategy in patients with transient STEMI.
Typical symptoms of myocardial infarction are more common and have greater predictive value in women than in men.
For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete revascularization is superior to culprit lesion-only percutaneous coronary intervention.
Investigators analyzed the use of single-measurement high-sensitivity cardiac troponin I to characterize patients at low and high risk for acute myocardial infarction.
